Atlas Trials

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

Clinical trial NCT00044720 · COMPLETED

Trial details

NCT number
NCT00044720
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Kidney FailureGraft vs Host DiseaseKidney Transplantation
Primary completion
2005-07-01
Enrollment
484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.